Aneel Arjun Ashrani MD

PubMed

• The global epidemiology of acquired factor X deficiency.
  Kristy Iglay, Molly L Aldridge, Mirella Calcinai, Eric Wolford, Aneel A Ashrani
  Hematology. 2025-12-01
• Evaluating the potential for iodinated radiocontrast agents to interfere with ADAMTS13 activity testing via fluorescence resonance energy transfer methodology.
  Jeremy W Jacobs, Melissa S Stuart, Julie I Tange, Rachel R Leger, Aneel A Ashrani
  American Journal of Clinical Pathology. 2025-04-19
• Corrigendum to 'Extending Venous Thromboembolism Secondary Prevention with Apixaban in Cancer Patients. The EVE Trial': [Journal of Thrombosis and Haemostasis Volume 2...
  Robert D McBane 2nd, Charles L Loprinzi, Tyler Zemla, Alfonso Tafur, Kristen Sanfilippo
  Journal of Thrombosis and Haemostasis. 2025-02-01

Journal Articles

• Venous Thromboembolism (VTE) Incidence and VTE-Associated Survival Among Olmsted County Residents of Local Nursing Homes  
  John A Heit, Aneel A Ashrani, Thrombosis and Haemostasis
• Rethinking guidelines for VTE risk among nursing home residents: A population-based study merging medical record detail with standardized nursing home assessments  
  Leibson CL, Petterson TM, Smith CY, Bailey KR, Emerson JA, Ashrani AA , Takahashi PY, Heit JA, Chest, 1/1/2014
• Monoclonal Gammopathy of Undetermined Significance (MGUS) in a Man with Fragile X-associated Tremor/Ataxia Syndrome  
  Sumekar TA, Ashrani AA , Winarni TI, Hagerman RJ, Case Reports in Genetics, 1/1/2011

Books/Book Chapters

• Coagulation in Cancer 
  Chapter: Risk Factors for Thrombosis in Cancer Patients. 
  Ashrani AA , Heit JAEditors: Green D, Kwaan HC.Springer, MA2009
• Coagulation in Cancer. 
  Chapter: Chemotherapy-Associated Thrombosis. 
  Ashrani AA , Rajkumar SVEditors: Green D, Kwaan HC.Springer, MA2009
• Thromboembolism in advanced disease-A clinical guide 
  Chapter: Epidemiology of venous thromboembolism. 
  Ashrani AA , Heit JAEditors: Noble S, Johnson M, Lee AYY.Oxford University Press, Oxford, UK2008
• Handbook of Blood Banking and Transfusion Medicine 
  Chapter: Hemorrhagic disorders in the surgical patient. 
  Ashrani AA , Key NSEditors: Rao GHR, Eastlund T, Jagannathan L.Jaypee Brothers Medical Publishers, New Delhi, India2005
• Handbook of Blood Banking and Transfusion Medicine 
  Chapter: Thrombotic disorders in the surgical patient. 
  Ashrani AA , Key NSEditors: Rao GHR, Eastlund T, Jagannathan L.Jaypee Brothers Medical Publishers, New Delhi, India2005
• Surgical Critical Care 
  Chapter: Disorders of coagulation. 
  Page 811 - 832Ashrani AA , Key NSEditors: Abrams JH, Druck P, Cerra FB.Taylor & Francis, Boca Raton, FLEdition 2nd,2005
• Join now to see all

Abstracts/Posters

• Incidental Pulmonary Embolism. Analysis of Mayo Clinic Venous Thromboembolism Database
  Aneel A. Ashrani, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Acquired von willebrand disease-to treat or not to treat the inhibitor?
  Curoe S, Shah S, Shinde S, Pruthi R, Ashrani A , Reding M, Haemophilia, 5/1/2014
• Venous thromboembolism incidence and mortality among nursing home (nh) residents: unique estimates afforded by merging nh and medical record data.
  Leibson C, Petterson T, Smith C, Bailey K, Emerson J, Ashrani A , Heit J, J Am Geriatr Soc, 4/1/2013
• Coagulation and Thrombosis.
  Aneel A. Ashrani, MD, ASH 2012: Interesting Abstracts, Mayo Clinic 10th Annual Hematology Review, Minneapolis, MN, 1/1/2013
• Trends in the incidence of venous thromboembolism adjusted for body mass index (bmi).
  Kevin CP, Ashrani AA , Petterson TM, Crusan DJ, Bailey KR, Heit JA, Blood, 11/16/2012
• Autoimmunity in patients (pts) with chronic myelomonocytic leukemia (cmml): a frequent finding.
  Swedeh A, Patnaik M, Alfakara D, Ashrani AA , Pruthi R, Elliott M, Litzow M, Al-Kali A, Blood, 11/16/2012
• Diffuse alveolar hemorrhage caused by primary antiphospholipid syndrome.
  Cartin-Ceba R, Peikert T, Keogh K, Ytterberg SR, Ashrani A , Specks U, Arthritis Rheum, 10/1/2012
• Impact of interim hospitalizations on risk of venous thromboembolism (vte) recurrence: a nested case-cohort study.
  Ashrani AA , Farmer SA, Petterson TM, Bailey KR, Leibson CL, Heit JA, Blood, 11/18/2011
• Risk factors for venous thromboembolism (VTE) among nursing home residents: a population based case control study.
  Leibson CL, Heit JA, Ashrani A , Bailey KR, Petterson TM, Smith CY, Blood, 11/19/2010
• Odds of venous thromboembolims (VTE) associated with hospitalization, surgery, and cancer among nursing home residents: a population-based study.
  Leibson CL, Heit JA, Bailey KR, Petterson TM, Ashrani A, Blood, 11/20/2009
• Systemic fibrinolysis due to t-PA producing metastatic breast cancer.
  Patnaik MM, Naina HV, Ali UA, Chen D, Ashrani AA, XXIInd Congress of the International Society on Thrombosis and Haemostasis, Boston, 7/1/2009
• Is progesterone an independent risk factor for incident vemnous thromboembolism (VTE)? A population-based case-control study.
  Barsoum M, Heit JA, Ashrani AA , Leibson CL, Petterson TM, Bailey KR, Melton III LJ, XXIInd Congress of the International Society on Thrombosis and Haemostasis, Boston, 7/1/2009
• Coagulation Topics.
  Aneel A. Ashrani, MD, ASH 2008: Interesting Abstracts, Mayo Clinic 6th Annual Hematology ASH Review, Minneapolis, MN, 1/1/2009
• Role of lipid lowering therapy (LLT) on venous thromboembolism (VTE) risk: A population-based case control study.
  Ashrani AA , Heit JA, Barsoum MK, Leibson CL, Petterson TM, Bailey KR, Melton LJ, J Thromb Haemost, 1/1/2009
• Incidence of cancer-associated venous thromboembolism (VTE): a population-based cohort study.
  Ashrani AA , Heit JA, Crusan DJ, Petterson TM, Bailey KR, Melton LJ, Blood, 11/1/2008
• Is diabetes mellitus an independent risk factor for incident venous thromboembolism (VTE)? A population-based case-control study.
  Heit JA, Leibson CL, Ashrani AA , Petterson TM, Bailey KR, Melton LJ, Blood, 11/1/2008
• Thrombotic Complications in Hematologic Malignancies.
  Aneel A. Ashrani, MD, 5th Mayo Clinic State of the Art Symposium: Hematologic Malignancies, Phoenix, AZ, 1/1/2008
• Risk factors for venous thromboembolism (VTE) among patients with active hematological cancer: A population-based case-control study.
  Ashrani AA , Heit JA, Schmoll JA, Farmer SA, Petterson TM, Melton LJ, Blood, 11/1/2007
• Hazard of subsequent hematological cancer in patients with incident venous thromboembolism (VTE): A population-based cohort study.
  Gangat N, Ashrani AA , Petterson TM, Schmoll J, Heit JA, Blood, 11/1/2007
• Update on the Management of Hypercoagulable States.
  Aneel A. Ashrani, MD, 17th Annual Mayo Clinic Hematology/Oncology Reviews, Amelia Islands, FL, 8/1/2007
• Impact of Venous Thromboembolism, Venous Stasis Syndrome, Venous Outflow Obstruction and Venous Valvular Incompetence on Quality of Life and Activities of Daily Living...
  Ashrani AA , Heit JA, Rooke TW, Lahr BD, Petterson TM, Bailey KR, Melton LJ III, XXIst Congress of the International Society on Thrombosis and Haemostasis, Geneva, Switzerland, 7/1/2007
• Risk Factors for Venous Thromboembolism (VTE) Among Active Cancer Patients: A Population-Based Case-Control Study (OT 006).
  Heit JA, Marks RS, Ashrani AA , Petterson TM, Bailey KR, Melton LJ III, XXIst Congress of the International Society on Thrombosis and Haemostasis, Geneva, Switzerland, 7/1/2007
• Tumor site and metastases as predictors of venous thromboembolism recurrence among active cancer patients with incident deep vein thrombosis or pulmonary embolism: a p...
  Chee CE, Heit JA, Ashrani AA , Petterson TM, Farmer SA, Bailey KR, Melton LJ III, Blood, 11/1/2006
• Role of venous outflow obstruction and venous valvular incompetence as mechanisms for venous stasis syndrome following deep vein thrombosis: a population-based cohort ...
  Ashrani AA , Heit JA, Lahr BD, Petterson TM, Bailey KR, Blood, 11/1/2006
• Characteristics of and Risk Factors for Septic Arthritis in Males with Hemophilia.
  Ashrani A , Key N, Duffy N, Forsyth A, Geraghty S, Abshire T, Curtis R, Drake J, Hoots W, Kuebler E, Konkle B, Kulkarni R, Nielsen B, Soucie J, Haemophilia, 5/1/2006
• Join now to see all

Lectures

• Impact of Length of Stay on Hospital-Associated Venous Thromboembolism (VTE) 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Bleeding and Thrombosing Diseases Conference 
  Mayo School of Continuous Professional Development, Rochester, Minnesota - 8/7/2013
• "An Update on Thrombosis" 
  Amelia Island, FL - 8/1/2011
• "Sickle Cell Disease" 
  Austin Medical Center, Austin, MN - 10/1/2010
• Approach to Bleeding Diathesis (Laboratory and Clinical Testing Corelations)." 
  Good Samaritan Hospital, Kearney, NE - 7/1/2007
• Hemophilia. 
  Vancouver, British Columbia, Canada - 5/1/2006
• Medicine Grand Rounds: "Venous Thromboembolism in Patients with Malignancy." 
  University of Minnesota, Minneapolis, MN - 3/1/2006
• "Update on Venous Thromboembolism." 
  Lake Region Hospital, Fergus Falls, MN - 2/1/2005
• "Catheter Directed Thrombolytic Therapy-Pros and Cons." 
  11/1/2004
• "Anticoagulation Update." 
  10/1/2004
• "Thrombolytic Therapy in DVT-Pros and Cons." 
  5/1/2004
• "Current Controversies Regarding the Optimal Intensity of Long Term Anticoagulation for Venous Thromboembolism." 
  11/1/2003
• "The Venous Disease Debate: Heparin versus Thrombolysis?" 
  10/1/2003
• "Pulmonary Embolism." 
  Stillwater, MN - 6/1/2003
• "Management of Anticoagulant Therapy." 
  4/1/2003
• "Outpatient Management of DVT." 
  12/1/2002
• "Thrombolytic Therapy versus Anticoagulation for DVT." 
  10/1/2002
• Medicine Grand Rounds: "Thrombotic Thrombocytopenic Purpura: An Update on De Novo TTP and Transplant-related Thrombotic Microangiopathy." 
  University of Minnesota - 3/1/2002
• "An Approach to the Evaluation of Bleeding Disorders." 
• Join now to see all

Other

• Fibrin and Fibrin Degradation Products. 
  Ashrani AA, AskMayoExpert (AME topic)
  http://javaprod.mayo.edu/ame/openTopic?collection=1&topicID=1242&page=search&epid=20#tabIndex=0
  1/1/2014
• Home International Normalized Ratio Monitoring. 
  Ashrani AA, AskMayoExpert (AME topic)
  http://javaprod.mayo.edu/ame/openTopic?collection=1&topicID=4427
  8/13/2013
• Factor X Chromogenic Activity Assay. 
  Ashrani AA, AskMayoExpert (AME topic)
  http://javaprod.mayo.edu/ame/openTopic?collection=1&topicID=4429
  8/8/2013
• Immune thrombocytopenia (ITP). 
  Ashrani AA, AskMayoExpert (AME topic)
  1/1/2013
• Platelet antibodies. 
  Ashrani AA, AskMayoExpert (AME topic)
  1/1/2013
• Thrombotic thrombocytopenic purpura. 
  Ashrani AA, AskMayoExpert (AME topic)
  1/1/2013
• Thalassemia syndromes. 
  Ashrani AA, AskMayoExpert (AME topic)
  1/1/2013
• Warfarin. 
  Ashrani AA, AskMayoExpert (AME topic)
  1/1/2013
• Heparin induced thrombocytopenia. 
  Ashrani AA, AskMayoExpert (AME topic)
  1/1/2013
• Thrombocytopenia. 
  Ashrani AA, AskMayoExpert (AME topic)
  1/1/2012
• von Willebrand disease. 
  Ashrani AA, AskMayoExpert (AME topic)
  1/1/2010
• Hemophilia. 
  Ashrani AA, AskMayoExpert (AME topic)
  1/1/2010
• Join now to see all